GSK Receives Approval for HYCAMTIN(R) (topotecan) Capsules for the Treatment of Relapsed Small Cell L...(company includingthose made in this Anno...),Health

Date:10/15/2007

company, including those made in this Announcement, are subject to risks and uncertainties that may cause actual results to differ materially from those projected. Factors that may affect the Group's operations are described under 'Risk Factors' in the 'Business Review' in the company's Annual Report on Form 20-F for 2006.

Note to Editors

To access the latest GSK Oncology media materials, visit http://www.gsk.com/media.

Enquiries:

US Media enquiries: Sarah Alspach +1 919 483 2839

Mary Anne Rhyne +1 919 483 2839

UK Media enquiries: Philip Thomson +44 20 8047 5502

Claire Brough +44 20 8047 5502

European Analyst/Investor Anita Kidgell +44 20 8047 5542

enquiries: Sally Ferguson +44 20 8047 5543

David Mawdsley +44 20 8047 5564

US Analyst/ Investor Frank Murdolo +1 215 751 7002

enquiries: Tom Curry +1 215 751 5419

References:

1. O'Brien M, Ciuleanu TE, Tsekov H, et al. Phase III Trial Comparing

Supportive Care Alone With Supportive Care With Oral Topotecan in

Patients With Relapsed Small-Cell Lung Cancer. J Clin Oncol.

2006;24:5441-5447.

2. HYCAMTIN capsules [package insert]. Research Triangle Park, NC:

GlaxoSmithKline; 2007.

3. American Cancer Society. Small Cell Lung Cancer Detailed Guide.

http://www.cancer.org/docroot/CRI/content/CRI_2_4_7x_Lung_Cancer_-

_Small_Cell_Detailed_Guide.asp. Accessed April 17, 2007.

'/>"/>

SOURCE GlaxoSmithKline Copyright©2007 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4
Related medicine technology :

1. Sirion Therapeutics Receives Orphan Drug Designation for Ophthalmic Drug to Treat Viral Eye Infection
2. Protalix BioTherapeutics, Inc. Receives Approval from the FDA to Initiate a Phase III Clinical Trial of prGCD
3. DUSA Pharmaceuticals Receives Orphan Drug Desi gnation for Levulan PDT to Treat Esophage al Dysplasia
4. Gloucester Pharmaceuticals Receives Fast Track Designation for Romidepsin in Peripheral T-Cell Lymphoma
5. Point of Care Strep Tests Speed Treatment, Lower Costs
6. Rapid HIV Testing Increases Possibility of Treatment
7. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
8. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
9. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
10. BusinessWeek Article Highlights Promising Breakthrough Treatment for Advanced Coronary Artery Disease
11. TransPharma Medical Announces Positive Results of Phase I Clinical Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis Treatment